Home > PJ (current issue) > Letters | Search

PJ Online homeThe Pharmaceutical Journal
Vol 273 No 7313 p255
21 August 2004

This article
Reprint   Photocopy

PDF 110K, Acrobat Reader

Letters

· Retention fee
· Shipman inquiry
· Politicians
· Simvastatin
· EHC
· Careers in pharmacy
· Packaging
· Wildlife
· The Charter
· Council elections


Letters to the Editor

Wildlife

Drug implicated in mass poisoning of wildlife

From Mr M. H. Espley, MRPharmS

I read with interest a report in BBC Wildlife October 2003, pp18–19, and also August 2004, p22, that diclofenac has been identified as the cause of a dramatic decline in Asian vultures over the past 10 years in the Indian subcontinent.

Diclofenac is widely used in the treatment of domestic livestock, the vultures’ primary source of food. It is the first time that a pharmaceutical drug has been implicated in mass poisoning of wildlife over an entire subcontinent. This has raised fears that the vulture population of South Asia is at risk of extinction.

Studies in India’s Keoladeo National Park during the late 1990s showed dramatic declines in breeding populations with alarming numbers of dead vultures. Regional population declines of more than 90 per cent were reported across India prompting the International Union for Conservation of Nature to list three vulture species as “critically endangered”.

Conservationists are now calling for prompt action to improve the scrutiny of the worldwide use of pharmaceuticals in the environment. In Pakistan, diclofenac is readily available without a prescription and costs less than 50p per 50ml bottle.

At a Wildlife Disease Association conference at Saskatoon, Canada, concerns were raised that other scavengers, for example, feral dogs, will fill any niche vacated by vultures and lead to an increase in rabies. A rise in anthrax is another, more contentious fear. Vultures typically consume a carcass soon after death has occurred and before anthrax can develop into a resistant form.

Malcolm H. Espley
Chester

Send your letter to The Editor

Previous Topic (Packaging)
Next Topic (The Charter)

Back to Top


©The Pharmaceutical Journal